• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.63% Nasdaq Up 1.78%

    Hyperion Therapeutics, Inc. (HPTX)

    -NasdaqGS
    22.10 Down 0.13(0.58%) 2:06PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:22.23
    Open:22.55
    Bid:22.08 x 100
    Ask:22.13 x 100
    1y Target Est:35.43
    Beta:0.7
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:21.71 - 22.55
    52wk Range:19.59 - 32.98
    Volume:237,014
    Avg Vol (3m):182,698
    Market Cap:457.98M
    P/E (ttm):N/A
    EPS (ttm):-0.64
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    HPTXDown 0.58%457.98M
    ALXNUp 3.52%37.37B
    CPIXUp 1.87%94.60M
    SLXPUp 1.46%7.40B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.54
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.94
    Quarterly EPS Est (Dec-14) :-0.24
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Hyperion Therapeutics, Inc., a commercial biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat disorders in the areas of orphan diseases and hepatology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback